BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol 2014; 20(32): 11033-11053 [PMID: 25170193 DOI: 10.3748/wjg.v20.i32.11033] [Cited by in CrossRef: 117] [Cited by in F6Publishing: 97] [Article Influence: 16.7] [Reference Citation Analysis]
Number Citing Articles
1 Catanzaro R, Aleo A, Sciuto M, Zanoli L, Balakrishnan B, Marotta F. FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study. Clin Exp Hepatol 2021;7:111-6. [PMID: 34027123 DOI: 10.5114/ceh.2021.104543] [Reference Citation Analysis]
2 Teran-Hinojosa E, Sobral H, Sánchez-Pérez C, Pérez-García A, Alemán-García N, Hernández-Ruiz J. Differentiation of fibrotic liver tissue using laser-induced breakdown spectroscopy. Biomed Opt Express 2017;8:3816-27. [PMID: 28856052 DOI: 10.1364/BOE.8.003816] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.8] [Reference Citation Analysis]
3 Li H, Wang X, Liu Y, Pan D, Wang Y, Yang N, Xiang L, Cai X, Feng Y. Hepatoprotection and hepatotoxicity of Heshouwu , a Chinese medicinal herb: Context of the paradoxical effect. Food and Chemical Toxicology 2017;108:407-18. [DOI: 10.1016/j.fct.2016.07.035] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 9.5] [Reference Citation Analysis]
4 Lefebvre T, Petitclerc L, Hébert M, Bilodeau L, Sebastiani G, Olivié D, Gao ZH, Sylvestre MP, Cloutier G, Nguyen BN, Gilbert G, Tang A. MRI cine-tagging of cardiac-induced motion for noninvasive staging of liver fibrosis. J Magn Reson Imaging 2020;51:1570-80. [PMID: 31605412 DOI: 10.1002/jmri.26935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Valiakou V, Eliadis P, Karamichali E, Tsitsilonis O, Koskinas J, Georgopoulou U, Foka P. Differential Expression of the Host Lipid Regulators ANGPTL-3 and ANGPTL-4 in HCV Infection and Treatment. Int J Mol Sci 2021;22:7961. [PMID: 34360721 DOI: 10.3390/ijms22157961] [Reference Citation Analysis]
6 Zakaria S, El-Sisi AE. Daclatasvir and Sofosbuvir Mitigate Hepatic Fibrosis Through Downregulation of TNF-α / NF-κB Signaling Pathway. Curr Mol Pharmacol 2020;13:318-27. [PMID: 31951178 DOI: 10.2174/1874467213666200116114919] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Petitclerc L, Gilbert G, Nguyen BN, Tang A. Liver Fibrosis Quantification by Magnetic Resonance Imaging. Top Magn Reson Imaging 2017;26:229-41. [PMID: 28858038 DOI: 10.1097/RMR.0000000000000149] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 5.7] [Reference Citation Analysis]
8 Librelotto CS, Souza AP, Álvares-DA-Silva MR, Simon D, Dihl RR. Evaluation of the genetic toxicity of sofosbuvir and simeprevir with and without ribavirin in a human-derived liver cell line. An Acad Bras Cienc 2021;93:e20200632. [PMID: 34586319 DOI: 10.1590/0001-3765202120200632] [Reference Citation Analysis]
9 Pan S, Wang XQ, Guo QY. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging. World J Gastroenterol 2018; 24(18): 2024-2035 [PMID: 29760545 DOI: 10.3748/wjg.v24.i18.2024] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
10 Yanny B, Saab S, Durazo F, Latt N, Mitry A, Mikhail MM, Hanna RM, Aziz A, Sahota A. Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL. Dig Dis Sci 2018;63:3480-6. [PMID: 30259281 DOI: 10.1007/s10620-018-5283-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Nozaki A, Chuma M, Hara K, Moriya S, Fukuda H, Numata K, Tanaka K, Morimoto M, Sakamaki K, Yamanaka T, Kondo M, Maeda S. Sofosbuvir-based therapies associated with regression of liver fibrosis in patients with hepatitis C virus infection: A prospective observational study. Medicine (Baltimore) 2021;100:e25110. [PMID: 33761674 DOI: 10.1097/MD.0000000000025110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Rewisha E, Salman T, Alhaddad O, Raia GA, Naguib M, Rashad S, Abdelfattah A, Metwally K, Abdelsameea E. Hyaluronic acid as a potential marker for assessment of fibrosis regression after direct acting antiviral drugs in chronic hepatitis C patients. Clin Exp Hepatol 2021;7:320-7. [PMID: 34712835 DOI: 10.5114/ceh.2021.109293] [Reference Citation Analysis]
13 Nandwana SB, Finazzo J, Alexander LF, Cox K. Using qualitative descriptors of chronic liver disease on MRI: A practice prone to error. Clin Imaging 2021;74:89-92. [PMID: 33461018 DOI: 10.1016/j.clinimag.2020.12.023] [Reference Citation Analysis]
14 Catanzaro R, Sciuto M, Lanzafame C, Balakrishnan B, Marotta F. Platelet to lymphocyte ratio as a predictive biomarker of liver fibrosis (on elastography) in patients with hepatitis C virus (HCV)-related liver disease. Indian J Gastroenterol 2020;39:253-60. [PMID: 32833144 DOI: 10.1007/s12664-020-01038-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Batsaikhan B, Lu MY, Yeh ML, Huang CI, Huang CF, Lin ZY, Chen SC, Huang JF, Hsieh PH, Chuang WL, Lee JC, Yu ML, Dai CY. Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis C. J Chin Med Assoc 2019;82:277-81. [PMID: 30946707 DOI: 10.1097/JCMA.0000000000000064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Irshad M, Gupta P, Irshad K. Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection. World J Hepatol 2017; 9(36): 1305-1314 [PMID: 29359013 DOI: 10.4254/wjh.v9.i36.1305] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
17 Sukalingam K, Ganesan K, Xu B. Protective Effect of Aqueous Extract from the Leaves of Justicia tranquebariesis against Thioacetamide-Induced Oxidative Stress and Hepatic Fibrosis in Rats. Antioxidants (Basel). 2018;7. [PMID: 29932107 DOI: 10.3390/antiox7070078] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
18 Matta B, Lee TH, Patel K. Use of Non-invasive Testing to Stage Liver Fibrosis in Patients with HIV. Curr HIV/AIDS Rep 2016;13:279-88. [PMID: 27485838 DOI: 10.1007/s11904-016-0329-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
19 Eser Karlidag G, Arslan Solmaz O. Are adropin, apelin, elabela, asprosin and betatrophin biomarkers for chronic hepatitis and staging of fibrosis? Biotech Histochem 2020;95:152-9. [PMID: 32011178 DOI: 10.1080/10520295.2020.1714732] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Guest JD, Pierce BG. Structure-Based and Rational Design of a Hepatitis C Virus Vaccine. Viruses 2021;13:837. [PMID: 34063143 DOI: 10.3390/v13050837] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Castelo A, Mello CEB, Teixeira R, Madruga JVR, Reuter T, Pereira LMMB, Silva GF, Álvares-DA-Silva MR, Zambrini H, Ferreira PRA. HEPATITIS C IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM: BURDEN OF DISEASE. Arq Gastroenterol 2018;55:329-37. [PMID: 30785514 DOI: 10.1590/S0004-2803.201800000-74] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
22 Conde I, Vinaixa C, Berenguer M. Hepatitis C-related cirrhosis. Current status. Med Clin (Barc) 2017;148:78-85. [PMID: 27855947 DOI: 10.1016/j.medcli.2016.09.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Dong S, Cai FF, Chen QL, Song YN, Sun Y, Wei B, Li XY, Hu YY, Liu P, Su SB. Chinese herbal formula Fuzheng Huayu alleviates CCl4-induced liver fibrosis in rats: a transcriptomic and proteomic analysis. Acta Pharmacol Sin 2018;39:930-41. [PMID: 29094729 DOI: 10.1038/aps.2017.150] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
24 Stief JD, Haase M, Lüdemann L, Theilig D, Schmelzle M, Hamm B, Denecke T, Geisel D. Combined morphological and functional liver MRI using spin-lattice relaxation in the rotating frame (T1ρ) in conjunction with Gadoxetic Acid-enhanced MRI. Sci Rep 2019;9:2083. [PMID: 30765741 DOI: 10.1038/s41598-018-37689-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Petitclerc L, Sebastiani G, Gilbert G, Cloutier G, Tang A. Liver fibrosis: Review of current imaging and MRI quantification techniques. J Magn Reson Imaging. 2017;45:1276-1295. [PMID: 27981751 DOI: 10.1002/jmri.25550] [Cited by in Crossref: 89] [Cited by in F6Publishing: 78] [Article Influence: 17.8] [Reference Citation Analysis]
26 Salzberger W, Martrus G, Bachmann K, Goebels H, Heß L, Koch M, Langeneckert A, Lunemann S, Oldhafer KJ, Pfeifer C, Poch T, Richert L, Schramm C, Wahib R, Bunders MJ, Altfeld M. Tissue-resident NK cells differ in their expression profile of the nutrient transporters Glut1, CD98 and CD71. PLoS One 2018;13:e0201170. [PMID: 30028872 DOI: 10.1371/journal.pone.0201170] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
27 Silberstein E, Ulitzky L, Lima LA, Cehan N, Teixeira-Carvalho A, Roingeard P, Taylor DR. HCV-Mediated Apoptosis of Hepatocytes in Culture and Viral Pathogenesis. PLoS One 2016;11:e0155708. [PMID: 27280444 DOI: 10.1371/journal.pone.0155708] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
28 Vidal-Castiñeira JR, López-Vázquez A, Diaz-Bulnes P, Díaz-Coto S, Márquez-Kisinousky L, Martínez-Borra J, Navascues CA, Sanz-Cameno P, de la Vega J, Astudillo A, Rodríguez M, López-Larrea C. Genetic contribution of endoplasmic reticulum aminopeptidase 1 polymorphisms to liver fibrosis progression in patients with HCV infection. J Mol Med (Berl) 2020;98:1245-54. [PMID: 32647953 DOI: 10.1007/s00109-020-01948-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Tsai FJ, Yang PY, Chen CJ, Li JP, Li TM, Chiou JS, Cheng CF, Chuang PH, Lin TH, Liao CC, Huang SM, Ban B, Liang WM, Lin YJ. Decreased overall mortality rate with Chinese herbal medicine usage in patients with decompensated liver cirrhosis in Taiwan. BMC Complement Med Ther 2020;20:221. [PMID: 32664975 DOI: 10.1186/s12906-020-03010-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Gaggini M, Carli F, Rosso C, Younes R, D'Aurizio R, Bugianesi E, Gastaldelli A. Altered Metabolic Profile and Adipocyte Insulin Resistance Mark Severe Liver Fibrosis in Patients with Chronic Liver Disease. Int J Mol Sci 2019;20:E6333. [PMID: 31888144 DOI: 10.3390/ijms20246333] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Ma C, Zhao M, Du Y, Jin S, Wu X, Zou H, Zhang Q, Gao L. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Qingdu Decoction against Chronic Liver Injury. Evid Based Complement Alternat Med 2021;2021:6661667. [PMID: 33747110 DOI: 10.1155/2021/6661667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Ryu B, Eo KY, Jang JJ, Kim CY, Lee JM, Oh H, Kim U, Kim J, Lee HH, Jung YM, Park JH. A case of active incomplete biliary cirrhosis in an aged female Japanese macaque (Macaca fuscata). J Med Primatol 2018. [PMID: 29726008 DOI: 10.1111/jmp.12347] [Reference Citation Analysis]
33 Lombardo SD, Lombardo S. Some stability results for a model of Hepatitis C including alanine aminotransferase and immune system. Int J Biomath 2020;13:2050080. [DOI: 10.1142/s1793524520500801] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Marangon CG, de Bitencorte JT, Michita RT, Lunge VR, Dos Santos DC, Álvares-da-Silva MR, Simon D. Association between MICA rs2596542 Polymorphism with the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients. Pathol Oncol Res 2020;26:1519-25. [PMID: 31471884 DOI: 10.1007/s12253-019-00738-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Choi JH, Kim SM, Lee GH, Jin SW, Lee HS, Chung YC, Jeong HG. Platyconic Acid A, Platycodi Radix-Derived Saponin, Suppresses TGF-1-induced Activation of Hepatic Stellate Cells via Blocking SMAD and Activating the PPAR Signaling Pathway. Cells 2019;8:E1544. [PMID: 31795488 DOI: 10.3390/cells8121544] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
36 Stuart JD, Salinas E, Grakoui A. Immune system control of hepatitis C virus infection. Curr Opin Virol. 2021;46:36-44. [PMID: 33137689 DOI: 10.1016/j.coviro.2020.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
37 Yu ML, Tsai WL, Chu CJ, Kao JH. Characteristics of patients with hepatitis C virus infection and antiviral treatment initiation in Taiwan: The MOSAIC study. Kaohsiung J Med Sci 2021;37:245-52. [PMID: 33089964 DOI: 10.1002/kjm2.12317] [Reference Citation Analysis]
38 Chan J, Gogela N, Zheng H, Lammert S, Ajayi T, Fricker Z, Kim AY, Robbins GK, Chung RT. Direct-Acting Antiviral Therapy for Chronic HCV Infection Results in Liver Stiffness Regression Over 12 Months Post-treatment. Dig Dis Sci 2018;63:486-92. [PMID: 28887750 DOI: 10.1007/s10620-017-4749-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 9.5] [Reference Citation Analysis]
39 Fernandes FF, Piedade J, Guimaraes L, Nunes EP, Chaves U, Goldenzon RV, Cardoso SW, Duarte J, Grinsztejn B, Veloso VG, Pereira G, Perazzo H. Effectiveness of direct-acting agents for hepatitis C and liver stiffness changing after sustained virological response. J Gastroenterol Hepatol. 2019;34:2187-2195. [PMID: 31062880 DOI: 10.1111/jgh.14707] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
40 Avramovic G, Reilly M, Cullen W, Macías J, McCombe G, McHugh T, Oprea C, Story A, Surey J, Sabin C, Bivegete S, Vickerman P, Walker J, Ward Z, Lambert JS. HEPCARE EUROPE- A case study of a service innovation project aiming at improving the elimination of HCV in vulnerable populations in four European cities. Int J Infect Dis 2020;101:374-9. [PMID: 32992012 DOI: 10.1016/j.ijid.2020.09.1445] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Shin SK, Lee JW, Ra H, Kwon OS, Shin JB, Jin YJ, Lee S, Han KJ, Kim YN, Kim TH, Kim YS, Kim JH. Durability of Sustained Virologic Response and Improvement of Fibrosis Markers after Daclatasvir and Asunaprevir Treatment in Genotype 1b Hepatitis C Virus-Infected Patients: a Real Life and Multicenter Study. J Korean Med Sci 2019;34:e264. [PMID: 31650719 DOI: 10.3346/jkms.2019.34.e264] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Maev IV, Kuznetsova EI, Andreev DN, Dicheva DT. [Diagnostic accuracy of predictive indexes of liver fibrosis in patients with chronic hepatitis C]. Ter Arkh 2020;92:24-8. [PMID: 32598714 DOI: 10.26442/00403660.2020.02.000261] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Tama M, Naylor P, Patel S, Altawil J, Gulati D, Antaki F, Mutchnick MG, Ehrinpreis M. Overestimate of Fibrosis by FIBROSpect® II in African Americans Complicates the Management of their Chronic Hepatitis C. J Clin Transl Hepatol 2016;4:12-9. [PMID: 27047767 DOI: 10.14218/JCTH.2015.00053] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
44 Ciccarelli N, Fabbiani M, Brita AC, De Marco R, Grima P, Gagliardini R, Borghetti A, Cauda R, Di Giambenedetto S. Liver fibrosis is associated with cognitive impairment in people living with HIV. Infection 2019;47:589-93. [PMID: 30784024 DOI: 10.1007/s15010-019-01284-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
45 Udomsinprasert W, Jittikoon J, Sukkho S, Pojarassangkul N, Sangroongruangsri S, Chaikledkaew U. Decreased circulating vitamin D reflects adverse outcomes of hepatitis C virus infection: A systematic review and meta-analysis. J Infect 2020;81:585-99. [PMID: 32553842 DOI: 10.1016/j.jinf.2020.06.025] [Reference Citation Analysis]
46 Connolly JC, Lim JK. Non-invasive Fibrosis Assessment of Patients with Hepatitis C: Application of Society Guidelines to Clinical Practice. Curr Hepatology Rep 2019;18:249-58. [DOI: 10.1007/s11901-019-00471-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Wang Y, Li Y, Zhang H, Zhu L, Zhong J, Zeng J, Meng C, Wu J, Wang T, Shi R, Yuan W, Jiang J, Liu P, Ma Y. Pharmacokinetics-based comprehensive strategy to identify multiple effective components in Huangqi decoction against liver fibrosis. Phytomedicine 2021;84:153513. [PMID: 33647776 DOI: 10.1016/j.phymed.2021.153513] [Reference Citation Analysis]
48 Salama M, Nomir M, Fahmi M, El-gayar A, El-shishtawy M. Potential Role of Microfibrillar-Associated Protein 4, Fibrotic Indices and Oxidative Stress in Hepatocellular Carcinoma. Sci Pharm 2018;86:44. [DOI: 10.3390/scipharm86040044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
49 Li M, Zhuang H, Wei L. How would China achieve WHO's target of eliminating HCV by 2030? Expert Rev Anti Infect Ther 2019;17:763-73. [PMID: 31578079 DOI: 10.1080/14787210.2019.1675509] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
50 Taylor J, Carr-Lopez S, Robinson A, Malmstrom R, Duncan K, Maniar A, Re ACD, Carmichael JM. Determinants of Treatment Eligibility in Veterans With Hepatitis C Viral Infection. Clin Ther 2017;39:130-7. [PMID: 27989619 DOI: 10.1016/j.clinthera.2016.11.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
51 Valva P, Ríos DA, De Matteo E, Preciado MV. Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage. World J Gastroenterol 2016; 22(4): 1367-1381 [PMID: 26819506 DOI: 10.3748/wjg.v22.i4.1367] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
52 Wu MS, Wang CH, Tseng FC, Yang HJ, Lo YC, Kuo YP, Tsai DJ, Tsai WT, Yu GY. Interleukin-17F expression is elevated in hepatitis C patients with fibrosis and hepatocellular carcinoma. Infect Agent Cancer 2017;12:42. [PMID: 28770001 DOI: 10.1186/s13027-017-0152-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
53 Zheng Y, Wang J, Wang J, Xie H, Zhao T. Effect of Curcumol on the Fenestrae of Liver Sinusoidal Endothelial Cells Based on NF-κB Signaling Pathway. Evid Based Complement Alternat Med 2020;2020:8590638. [PMID: 32595742 DOI: 10.1155/2020/8590638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
54 Reyes-Avilés E, Kostadinova L, Rusterholtz A, Cruz-Lebrón A, Falck-Ytter Y, Anthony DD. Presence of Rheumatoid Factor during Chronic HCV Infection Is Associated with Expansion of Mature Activated Memory B-Cells that Are Hypo-Responsive to B-Cell Receptor Stimulation and Persist during the Early Stage of IFN Free Therapy. PLoS One 2015;10:e0144629. [PMID: 26649443 DOI: 10.1371/journal.pone.0144629] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
55 Gomes NBN, Torres US, Ferraz MLCG, D'Ippolito G. Autoimmune hepatitis in practice, from diagnosis to complications: What is the role of imaging? A clinicoradiological review. Clin Imaging 2021;74:31-40. [PMID: 33429144 DOI: 10.1016/j.clinimag.2020.12.032] [Reference Citation Analysis]
56 Abo El-Khair SM, El-Alfy HA, Elsamanoudy AZ, Elhammady D, Abd-Elfattah N, Eldeek B, Farid K. Development of a novel glycated protein-based fibrosis prediction score for determination of significant liver fibrosis in HCV-infected patients, a preliminary study. J Med Virol 2020. [PMID: 32558950 DOI: 10.1002/jmv.26204] [Reference Citation Analysis]
57 Sepulveda-Crespo D, Resino S, Martinez I. Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis. Drugs 2021;81:419-43. [PMID: 33400242 DOI: 10.1007/s40265-020-01458-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Bao YL, Wang L, Pan HT, Zhang TR, Chen YH, Xu SJ, Mao XL, Li SW. Animal and Organoid Models of Liver Fibrosis. Front Physiol 2021;12:666138. [PMID: 34122138 DOI: 10.3389/fphys.2021.666138] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Sáez-Royuela F, Linares P, Cervera LA, Almohalla C, Jorquera F, Lorenzo S, García I, Karpman G, Badia E, Vallecillo MA, Moncada A, Calvo S, Olcoz JL; Castile and Leon Hepatology Association (ACyLHE). Evaluation of advanced fibrosis measured by transient elastography after hepatitis C virus protease inhibitor-based triple therapy. Eur J Gastroenterol Hepatol 2016;28:305-12. [PMID: 26636405 DOI: 10.1097/MEG.0000000000000533] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
60 Mihai F, Trifan A, Stanciu C, Singeap AM, Cucuteanu B, Lupascu Ursulescu C, Pop C, Girleanu I, Cuciureanu T, Negru D, Cojocariu C. Liver Remodeling on CT Examination in Patients with HCV Compensated Cirrhosis Who Achieved Sustained Virological Response after Direct-Acting Antivirals Treatment. Medicina (Kaunas) 2020;56:E171. [PMID: 32290305 DOI: 10.3390/medicina56040171] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Lim S, Kim SH, Kim Y, Cho YS, Kim TY, Jeong WK, Sohn JH. Coefficient of Variance as Quality Criterion for Evaluation of Advanced Hepatic Fibrosis Using 2D Shear-Wave Elastography: Coefficient of Variance as Quality Criterion for Liver Fibrosis. J Ultrasound Med 2018;37:355-62. [DOI: 10.1002/jum.14341] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
62 Goñi Esarte S, Juanbeltz R, Zozaya JM, Úriz JI, Castilla J, Herrero JI. Modification of liver fibrosis, glucose and lipid profile after hepatitis C virus clearance with direct-acting antiviral agents. Gastroenterol Hepatol 2020;43:248-55. [PMID: 32192765 DOI: 10.1016/j.gastrohep.2019.03.017] [Reference Citation Analysis]
63 Imai H, Kamei H, Onishi Y, Ishizu Y, Ishigami M, Goto H, Ogura Y. Diagnostic Usefulness of APRI and FIB-4 for the Prediction of Liver Fibrosis After Liver Transplantation in Patients Infected with Hepatitis C Virus. Transplant Proc 2018;50:1431-6. [PMID: 29705278 DOI: 10.1016/j.transproceed.2018.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
64 Taneja S, Tohra S, Duseja A, Dhiman RK, Chawla YK. Noninvasive Assessment of Liver Fibrosis By Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C-An Experience from a Tertiary Care Hospital. J Clin Exp Hepatol 2016;6:282-90. [PMID: 28003717 DOI: 10.1016/j.jceh.2016.08.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
65 Mohamed MS, Hanafy AS, Bassiony MAA, Hussein S. Sofosbuvir and daclatasvir plus ribavirin treatment improve liver function parameters and clinical outcomes in Egyptian chronic hepatitis C patients. Eur J Gastroenterol Hepatol. 2017;29:1368-1372. [PMID: 28953002 DOI: 10.1097/meg.0000000000000963] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
66 Takamizawa S, Yamada T, Kitamura K, Hiraoka E. Difficulty of acute hepatitis C diagnosis in a hospitalised patient. BMJ Case Rep 2018;11:e226907. [PMID: 30567115 DOI: 10.1136/bcr-2018-226907] [Reference Citation Analysis]
67 Dadabhai AS, Saberi B, Lobner K, Shinohara RT, Mullin GE. Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data. World J Hepatol 2017; 9(5): 278-287 [PMID: 28261385 DOI: 10.4254/wjh.v9.i5.278] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
68 Jenkins G. Demystifying pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2020;319:L554-9. [PMID: 32755321 DOI: 10.1152/ajplung.00365.2020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
69 Hahn D, Stokes CS, Kaiser R, Meyer MR, Lammert F, Gruenhage F. Antidepressant effects of direct-acting antivirals against hepatitis C virus-Results from a pilot study. Eur J Clin Invest 2018;48:e13024. [PMID: 30175442 DOI: 10.1111/eci.13024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
70 Khatun M, Ray RB. Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis. Cells 2019;8:E1249. [PMID: 31615075 DOI: 10.3390/cells8101249] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 21.5] [Reference Citation Analysis]
71 Dalbeni A, Romano S, Bevilacqua M, Piccoli A, Imbalzano E, Mantovani A, Benati M, Montagnana M, Donato A, Torin G, Monaco C, Cattazzo F, Tagetti A, Paon V, Ieluzzi D, Iogna Prat L, Roccarina D, Ribichini F, Capra F, Minuz P, Fava C. Beneficial effects of DAAs on cardiac function and structure in hepatitis C patients with low-moderate liver fibrosis. J Viral Hepat 2020;27:1214-21. [PMID: 32593212 DOI: 10.1111/jvh.13355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
72 Ahn SH, Choe WH, Kim YJ, Heo J, Latarska-Smuga D, Kang J, Paik SW. Impact of Interferon-Based Treatment on Quality of Life and Work-Related Productivity of Korean Patients with Chronic Hepatitis C. Gut Liver 2020;14:368-76. [PMID: 31533395 DOI: 10.5009/gnl18100] [Reference Citation Analysis]
73 Schmilovitz-Weiss H, Gingold-Belfer R, Grossman A, Issa N, Boltin D, Beloosesky Y, Morag Koren N, Meyerovitch J, Weiss A. Lowering the upper limit of serum alanine aminotransferase levels may reveal significant liver disease in the elderly. PLoS One 2019;14:e0212737. [PMID: 30973940 DOI: 10.1371/journal.pone.0212737] [Reference Citation Analysis]
74 Lin J, Mauntel-Medici C, Maheswaran AB, Baghikar S, Pugach O, Stein EM, Martin MT, Nguyen H. Factors predicting staging and treatment initiation for patients with chronic hepatitis C infection: insurance a key predictor. J Public Health (Oxf) 2021:fdaa276. [PMID: 33539524 DOI: 10.1093/pubmed/fdaa276] [Reference Citation Analysis]
75 Kennedy P, Wagner M, Castéra L, Hong CW, Johnson CL, Sirlin CB, Taouli B. Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions. Radiology 2018;286:738-63. [PMID: 29461949 DOI: 10.1148/radiol.2018170601] [Cited by in Crossref: 119] [Cited by in F6Publishing: 108] [Article Influence: 39.7] [Reference Citation Analysis]
76 Jamhiri I, Shahin K, Khodabandeh Z, Kalantar K, Sarvari J, Atapour A, Mina F, Ahmadnejad A, Hosseini SY. Recombinant NS3 Protein Induced Expression of Immune Modulatory Elements in Hepatic Stellate Cells During Its Fibrotic Activity. Viral Immunol 2018;31:575-82. [PMID: 30281404 DOI: 10.1089/vim.2018.0018] [Reference Citation Analysis]
77 Jamil Z, Durrani AA. Assessing the outcome of patients with liver cirrhosis during hospital stay: A comparison of lymphocyte/monocyte ratio with MELD and Child-Pugh scores. Turk J Gastroenterol 2018;29:308-15. [PMID: 29755015 DOI: 10.5152/tjg.2018.17631] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
78 Song Z, Wu T, Sun J, Wang H, Hua F, Nicolas YSM, Kc R, Chen K, Jin Z, Liu J, Zhang M. Metformin attenuates post-epidural fibrosis by inhibiting the TGF-β1/Smad3 and HMGB1/TLR4 signaling pathways. J Cell Mol Med 2021;25:3272-83. [PMID: 33611840 DOI: 10.1111/jcmm.16398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 El Aggan H, Farahat N, El Deeb N, Zeid A, El-Shendidi A. Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury. Microb Pathog 2019;131:65-74. [PMID: 30926417 DOI: 10.1016/j.micpath.2019.03.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
80 Taniguchi T, Asano Y, Nakamura K, Yamashita T, Saigusa R, Ichimura Y, Takahashi T, Toyama T, Yoshizaki A, Sato S. Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis. J Rheumatol 2017;44:1198-205. [DOI: 10.3899/jrheum.161092] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
81 Zhou Y, Wu R, Cai FF, Zhou WJ, Lu YY, Zhang H, Chen QL, Su SB. Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFβ/Smad and Akt/FoxO3 signaling pathways based on network pharmacology analysis. J Ethnopharmacol 2021;264:113021. [PMID: 32479885 DOI: 10.1016/j.jep.2020.113021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
82 Chen CY, Wang TY, Chen WM, Chen KH, Yang YH, Chen PC, Chen VC. Bilateral oophorectomy and the risk of hepatocellular carcinoma in women with hepatitis C: A population-based study. Maturitas 2021;146:11-7. [PMID: 33722359 DOI: 10.1016/j.maturitas.2020.12.006] [Reference Citation Analysis]
83 Attar BM, Van Thiel DH. Hepatitis C virus: A time for decisions. Who should be treated and when? World J Gastrointest Pharmacol Ther 2016; 7(1): 33-40 [PMID: 26855810 DOI: 10.4292/wjgpt.v7.i1.33] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
84 Hsieh YH, Signer D, Patel AV, Viertel V, Saheed M, Irvin R, Sulkowski MS, Thomas DL, Rothman RE. Advanced liver fibrosis and care continuum in emergency department patients with chronic hepatitis C. Am J Emerg Med 2019;37:286-90. [PMID: 30409463 DOI: 10.1016/j.ajem.2018.08.067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
85 Smith AD, Branch CR, Zand K, Subramony C, Zhang H, Thaggard K, Hosch R, Bryan J, Vasanji A, Griswold M, Zhang X. Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis. Radiology 2016;280:771-81. [DOI: 10.1148/radiol.2016151542] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 10.2] [Reference Citation Analysis]
86 Akil A, Endsley M, Shanmugam S, Saldarriaga O, Somasunderam A, Spratt H, Stevenson HL, Utay NS, Ferguson M, Yi M. Fibrogenic Gene Expression in Hepatic Stellate Cells Induced by HCV and HIV Replication in a Three Cell Co-Culture Model System. Sci Rep 2019;9:568. [PMID: 30679661 DOI: 10.1038/s41598-018-37071-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
87 Derbala M, Elbadri ME, Amer AM, AlKaabi S, Sultan KH, Kamel YM, Elsayed EHS, Avades TY, Chandra P, Shebl FM. Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection. World J Gastroenterol 2015; 21(46): 13132-13139 [PMID: 26674154 DOI: 10.3748/wjg.v21.i46.13132] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
88 Xie H, Xie D, Zhang J, Jin W, Li Y, Yao J, Pan Z, Xie D. ROS/NF-κB Signaling Pathway-Mediated Transcriptional Activation of TRIM37 Promotes HBV-Associated Hepatic Fibrosis. Mol Ther Nucleic Acids 2020;22:114-23. [PMID: 32916597 DOI: 10.1016/j.omtn.2020.08.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
89 Fan C, Wu FR, Zhang JF, Jiang H. A Network Pharmacology Approach to Explore the Mechanisms of Shugan Jianpi Formula in Liver Fibrosis. Evid Based Complement Alternat Med 2020;2020:4780383. [PMID: 32617108 DOI: 10.1155/2020/4780383] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
90 Jamil Z, Arif S, Khan A, Durrani AA, Yaqoob N. Vitamin D Deficiency and Its Relationship with Child-Pugh Class in Patients with Chronic Liver Disease. J Clin Transl Hepatol 2018;6:135-40. [PMID: 29951357 DOI: 10.14218/JCTH.2017.00055] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
91 Wu L, Qiu W, Sun J, Wang J. SENP1 attenuates the liver fibrosis through down-regulating the expression of SMAD2. Biochem Biophys Res Commun 2018;495:755-60. [PMID: 29128362 DOI: 10.1016/j.bbrc.2017.11.047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
92 Morry J, Ngamcherdtrakul W, Yantasee W. Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles. Redox Biol 2017;11:240-53. [PMID: 28012439 DOI: 10.1016/j.redox.2016.12.011] [Cited by in Crossref: 147] [Cited by in F6Publishing: 135] [Article Influence: 29.4] [Reference Citation Analysis]
93 Coyle JR, Goerge E, Kacynski K, Rodgers R, Raines P, Vail LS, Lowhim S. Hepatitis C Virus Infections Associated with Unsafe Injection Practices at a Pain Management Clinic, Michigan, 2014-2015. Pain Med 2017;18:322-9. [PMID: 28204717 DOI: 10.1093/pm/pnw157] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
94 Zhao Y, Xing H, Wang X, Ou W, Zhao H, Li B, Li Y, Duan Y, Zhuang L, Li W, Cheng D, Quan M, Zhang Y, Ji S. Management of Diabetes Mellitus in Patients with Chronic Liver Diseases. J Diabetes Res 2019;2019:6430486. [PMID: 31915709 DOI: 10.1155/2019/6430486] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
95 Kotha S, Neong S, Patel K. Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinoma. Expert Rev Mol Diagn 2018;18:713-22. [PMID: 30019978 DOI: 10.1080/14737159.2018.1496020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
96 Dillon JF, Miller MH, Robinson EM, Hapca A, Rezaeihemami M, Weatherburn C, Mcintyre PG, Bartlett B, Donnan PT, Boyd KA, Dow E. Intelligent liver function testing (iLFT): A trial of automated diagnosis and staging of liver disease in primary care. Journal of Hepatology 2019;71:699-706. [DOI: 10.1016/j.jhep.2019.05.033] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
97 Wu R, Dong S, Cai FF, Chen XL, Yang MD, Liu P, Su SB. Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis. Molecules 2019;24:E338. [PMID: 30669350 DOI: 10.3390/molecules24020338] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]